SANA BIOTECHNOLOGY INC. - COMMON STOCK

Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates

26 Jun 2021 07:42:38 By Nasdaq GlobeNewswire

Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting

14 Jun 2021 06:15:00 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

02 Jun 2021 13:05:00 By Nasdaq GlobeNewswire

Sana Biotechnology Reports First Quarter 2021 Financial Results and Business Updates

05 May 2021 13:05:01 By Nasdaq GlobeNewswire

Sana Biotechnology to Present at the BofA Securities 2021 Healthcare Conference

04 May 2021 13:05:00 By Nasdaq GlobeNewswire

Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021

27 Apr 2021 13:35:00 By Nasdaq GlobeNewswire

Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021

09 Apr 2021 06:00:00 By Nasdaq GlobeNewswire

Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates

24 Mar 2021 13:10:00 By Nasdaq GlobeNewswire

FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies

17 Mar 2021 06:00:00 By Nasdaq GlobeNewswire

Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

08 Feb 2021 14:23:48 By Nasdaq GlobeNewswire

Sana Announces Upsized Pricing of Initial Public Offering

03 Feb 2021 20:22:22 By Nasdaq GlobeNewswire